Advertisement


Abbvie
Business  /  Published 24.12.18

Lupin in drug licence pact with US firm

Pharma major Lupin Ltd and the US-based AbbVie on Monday announced a partnership to develop and commercialise the former’s novel drug to treat hematological cancers.Under the pact, AbbVie, a biophar...
By Our Bureau in Mumbai


Advertisement

Download our latest App

to get update on the go...


Advertisement
 
Copyright © 2020 The Telegraph. All rights reserved.